Subject: Stock Exchange Release published on 6 May 2009 at 9.30 a.m. EET: Orion reacquires rights for i.v. levosimendan (Simdax®)
A teleconference is arranged today, Wednesday, 6 May 2009, starting at 11.00 a.m. EET for analysts and the media on the reacquisition of rights for Simdax. The teleconference will be hosted by Jari Karlson, CFO, and Dr. Liisa Hurme, SVP, Proprietary Products. The language of the teleconference is English.
The phone numbers to the conference call are:
when calling from the USA: +1 877 491 0064
when calling from other countries: +44 (0)20 7162 0025
The event can be followed live via Orion's website at www.orion.fi/english.
The slides to be presented at the teleconference are available at www.orion.fi/english.
Orion Corporation
Terhi Ormio
VP, Communications
Contact person for the teleconference:
Susanna Siira, IR Manager, phone +358 10 426 2782
Puplisher:
Orion Corporation